FibroGen amends bylaws to lower stockholder quorum to one-third from majority

KYNTRA BIO, INC.

Board adopted Amended and Restated Bylaws effective April 2, 2025.
Quorum reduced to holders of at least one-third of outstanding shares, down from majority.
Separate class quorum also changed to one-third of voting power.
Amendment applies to all stockholder meetings; no other bylaw changes disclosed.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.98

KYNTRA BIO, INC.: Amended bylaws to reduce stockholder meeting quorum requirement from a majority to at least one-third of outstanding shares entitled to vote (effective 2025-04-02).

Change: bylaw amendment
Effective: 2025-04-02

Exact text from the filing

On April 2, 2025, the board of directors of FibroGen, Inc. (the “Company”) amended and restated the Company’s amended and restated bylaws (as amended and restated, the “Amended and Restated Bylaws”), effective immediately.

View on SEC.gov

Browse all governance changes →

KYNTRA BIO, INC. filing history →

Source: SEC EDGAR

accession 0000950170-25-051219

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.